TLR4 and endothelial dysfunction: In contrast, a dysbiotic microbiome enriched in Gram‐negative bacteria can release lipopolysaccharide (LPS) into circulation when intestinal permeability is impaired, activating the TLR4/NF‐κB pathway and promoting systemic inflammation and endothelial dysfunction [35].